Marco Merino has been appointed as Chief Information Officer (CIO) of Veritas Intercontinental, Europe & Latam, a subsidiary of Veritas Genetics, The Genome Company.

Engineer from the University of Cantabria, Marco Merino’s curriculum is completed with a Postgraduate in General Management Program (PDG) by the IESE Business School and a Master’s Degree in Information Technology and Communications from the Polytechnic University of Madrid (UPM).

As Chief Information Officer of Veritas Int. and member of the Executive Committee, Marco Merino will be responsible for the development of Veritas Int.’s technology and bioinformatics platforms. He will be coordinating the global group of experts to ensure the integrity of the information, besides he will be focusing technological advances on genomic products to offer the best solutions in the portfolio of Veritas Int.

Before joining Veritas, Marco Merino has been Corporate CIO of Chemo Group, Global Service IT Director of NGA Human Resources, EMEA IT Lead of Computer Sciences Corporation and CIO of Marconi Communications Iberia.

 

About Veritas Intercontinental

Veritas Intercontinental is the international subsidiary of Veritas Genetics, The Genome Company, which operates in Europe, Latin America, Japan and UAE. Its mission is to promote whole genome and offer people information that empowers them to maximize the quality and duration of their lives and their families, changing the way in which the world conceives genetics.

Veritas was the first company to offer whole genome sequencing and interpretation to consumers and their physicians and leads the field of genetics, expanding the limits of science and technology and reducing the cost of the genome.

 

Veritas was founded in 2014 by leaders in genomics at the Harvard Medical School and operates worldwide from its offices in the United States, Europe and China. The company has been recognized by MIT Technology Review as one of the 50 Smartest Companies in 2016 and 2017, by Fast Company as one of the most innovative healthcare companies in the world in 2018, and by CNBC as one of the Disruptor 50 companies in 2018.

For more information about our counseling service, our genetic tests or any questions you may have, contact us.